Delivery Order SPE2DB22D3004-SPE2DB23FQA31

Award Date 5/2/23
Potential Completion Date 5/3/23
Potential Value $3.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,653.28, is a Firm Fixed Price Delivery Order for the supply of Esomeprazole Magnesium Delayed-Release 40 mg Capsules in 30-count packages. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This federal contract award, valued at $1,887.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,721,129 units of Esomeprazole Magnesium Delayed-Release 20 mg Capsules in 90-count bottles. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of March 28, 2025. It is not designated as a set-aside contract. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,525,714 units of Esomeprazole Magnesium Delayed-Release 40 mg Capsules in 90-count bottles. The contract has an ultimate completion date of October 19, 2023, with a ceiling value of $1,103.34. The contract is a Firm Fixed Price Delivery Order, awarded without any set-aside...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $1,288.94, is for the delivery of Esomeprazole Magnesium Delayed-Release Capsules, 20 mg, in 90-count bottles. This contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The...
This federal contract award, valued at $1,304.54, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of esomeprazole magnesium delayed-release 20 mg capsules in quantities of 1,000. The contract has a completion date of May 10, 2024 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
This federal contract award, with ID SPE2DB20D3101|SPE2DB21FK4B4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,032.28 firm fixed-price delivery order is for the supply of Esomeprazole Magnesium Delayed-Release 40mg capsules. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) for the procurement of 4,562,312,674 units of Esomeprazole Magnesium Delayed-Release 20 mg Capsules in 90-count bottles. The contract has a firm fixed price of $14,810.61 and a period of performance ending on September 27, 2023. The award was made on September 26, 2023, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of 4,563,802,149 units of esomeprazole magnesium delayed-release 20 mg capsules in 90-count bottles. The $3,445.05 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has a completion date of February 29, 2024 and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,119.28 Firm Fixed Price Delivery Order is for the provision of esomeprazole magnesium delayed-release capsules to support military healthcare programs. The contract has an ultimate completion date of June 16, 2023 and was awarded on June 15, 2023 with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of Esomeprazole Magnesium Delayed-Release capsules, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a ceiling value of $1,696.24. The contract is a delivery order with a firm fixed price type and has an ultimate completion date of February 28, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB23FQA31
    Delivery Order

This federal contract award, with the ID SPE2DB22D3004|SPE2DB23FQA31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract covers the delivery of 4560801172 - Esomeprazole Magnesium Delayed-Release Capsules, 20 mg, in quantities of 90 per bottle. The contract has a firm fixed price of $3,310.10 and a completion date of May 3, 2023. This award is not designated under any set-aside program.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 5/9/25, 10:03 AM